These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36647666)

  • 41. Activity of voriconazole, a new triazole, combined with neutrophils or monocytes against Candida albicans: effect of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor.
    Vora S; Purimetla N; Brummer E; Stevens DA
    Antimicrob Agents Chemother; 1998 Apr; 42(4):907-10. PubMed ID: 9559806
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Monitoring and impact of fluconazole serum and cerebrospinal fluid concentration in HIV-associated cryptococcal meningitis-infected patients.
    Manosuthi W; Chetchotisakd P; Nolen TL; Wallace D; Sungkanuparph S; Anekthananon T; Supparatpinyo K; Pappas PG; Larsen RA; Filler SG; Andes D;
    HIV Med; 2010 Apr; 11(4):276-81. PubMed ID: 20002501
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates and clinical outcomes of cryptococcal meningitis in HIV-infected patients with/without fluconazole prophylaxis.
    Manosuthi W; Sungkanuparph S; Thongyen S; Chumpathat N; Eampokalap B; Thawornwan U; Foongladda S
    J Med Assoc Thai; 2006 Jun; 89(6):795-802. PubMed ID: 16850679
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interleukin-17 mediated differences in the pathogenesis of HIV-1-associated tuberculous and cryptococcal meningitis.
    Marais S; Meintjes G; Lesosky M; Wilkinson KA; Wilkinson RJ
    AIDS; 2016 Jan; 30(3):395-404. PubMed ID: 26765934
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Voriconazole treatment in adults and children with hematological diseases: can it be used without measurement of plasma concentration?
    Girmenia C; Annino L; Bertaina A; Mariotti B; Caselli D; Fanci R; Barberi W; Marchesi F; Carotti A; Ferrari A; Cerchiara E; Cupelli L; Arcioni F; Ribersani M; Proia A; Cartoni C; Girardi K; Venditti A; Cassetta MI; Fallani S; Novelli A
    Med Mycol; 2018 Apr; 56(3):263-278. PubMed ID: 28992093
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cryptococcal meningitis in Lilongwe and Blantyre, Malawi.
    Maher D; Mwandumba H
    J Infect; 1994 Jan; 28(1):59-64. PubMed ID: 8163834
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quantitative determination of voriconazole by thionine reduction and its potential application in a pharmaceutical and clinical setting.
    Ladetto MF; Lázaro-Martínez JM; Devoto TB; Briceño VJ; Castro GR; Cuestas ML
    Anal Methods; 2023 Mar; 15(9):1230-1240. PubMed ID: 36807654
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Measurement of antifungal drug levels in cerebrospinal fluid for cryptococcal meningoencephalitis.
    Shoji H; Takuma T; Ohbayashi H; Yoshida K; Yamamoto T; Niki Y
    J Infect Chemother; 2012 Oct; 18(5):775-9. PubMed ID: 22318291
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cerebrospinal fluid pleocytosis in immunocompromised patients: Can it be Cryptococcus.
    Sood R; Tyagi R; Selhi P; Kaur H; Sood N
    Diagn Cytopathol; 2020 Feb; 48(2):164-168. PubMed ID: 31714023
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings.
    Sloan D; Dlamini S; Paul N; Dedicoat M
    Cochrane Database Syst Rev; 2008 Oct; (4):CD005647. PubMed ID: 18843697
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Factors influencing cerebrospinal fluid and plasma HIV-1 RNA detection rate in patients with and without opportunistic neurological disease during the HAART era.
    Christo PP; Greco DB; Aleixo AW; Livramento JA
    BMC Infect Dis; 2007 Dec; 7():147. PubMed ID: 18096083
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytokine profiles in cerebrospinal fluid of patients with meningitis at a tertiary general hospital in China.
    Liu Q; Gao Y; Zhang B; Sun F; Yang Q; Liu Y; Wu J; Chen K; Weng X; Zhang W; Huang R; Shao L
    J Microbiol Immunol Infect; 2020 Apr; 53(2):216-224. PubMed ID: 30448438
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of cytochrome P450 gene polymorphism in a lupus nephritis patient in whom tacrolimus blood concentration was markedly elevated after administration of azole antifungal agents.
    Fujita Y; Araki T; Okada Y; Aomori T; Shimizu R; Tomizawa T; Hiromura K; Nojima Y; Nakamura T; Yamamoto K
    J Clin Pharm Ther; 2013 Feb; 38(1):74-6. PubMed ID: 22971159
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk factors and outcomes of cerebrospinal fluid overdrainage in HIV-negative patients with cryptococcal meningitis after the ventriculoperitoneal shunting procedure.
    Hung CW; Lin WC; Chang WN; Su TM; Kung CT; Tsai NW; Wang HC; Huang CC; Cheng BC; Su YJ; Chang YT; Su CM; Hsiao SY; Lu CH
    J Microbiol Immunol Infect; 2018 Aug; 51(4):545-551. PubMed ID: 28693927
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative efficacies of conventional amphotericin b, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis.
    Clemons KV; Espiritu M; Parmar R; Stevens DA
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4867-75. PubMed ID: 16304147
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Variables that influence HIV-1 cerebrospinal fluid viral load in cryptococcal meningitis: a linear regression analysis.
    Cecchini DM; Cañizal AM; Rojas H; Arechavala A; Negroni R; Bouzas MB; Benetucci JA
    J Int AIDS Soc; 2009 Nov; 12():33. PubMed ID: 19906308
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 'Time-to-amphotericin B' in cryptococcal meningitis in a European low-prevalence setting: analysis of diagnostic delays.
    Katchanov J; von Kleist M; Arastéh K; Stocker H
    QJM; 2014 Oct; 107(10):799-803. PubMed ID: 24722846
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of the Biofire FilmArray meningitis/encephalitis assay for the detection of Cryptococcus neoformans/gattii.
    Van TT; Kim TH; Butler-Wu SM
    Clin Microbiol Infect; 2020 Oct; 26(10):1375-1379. PubMed ID: 31972318
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cryptococcal meningitis in human immunodeficiency virus (HIV)-positive and HIV-negative patients.
    Viriyavejakul P; Tangwanicharoen T; Punpoowong B; Chaisri U; Wilainam P; Nuntakomon D; Yimsamran S; Maneerat Y; Pongponratn E; Wilairatana P; Riganti M
    Southeast Asian J Trop Med Public Health; 2004; 35 Suppl 2():33-8. PubMed ID: 15906631
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy and safety of lenalidomide in HIV-associated cryptococcal meningitis patients with persistent intracranial inflammation: an open-label, single-arm, prospective interventional study.
    Wan Z; Tao R; Hui J; Liu X; Peng X; Guo Y; Zhu X; Huang Y; Zhu B
    J Neuroinflammation; 2023 Feb; 20(1):38. PubMed ID: 36793113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.